Study set to delay recruitment after warning participants should be a minimum of 14 years old A clinical trial into puberty blockers for children has been paused after the medicines regulator warned it should have a minimum age limit of 14 because of the “unquantified risk” of “long-term biological harms”. Discussions between the Medicines and Healthcare products Regulatory Agency (MHRA) and the trial sponsor, King’s College London, will begin next week to discuss the wellbeing concerns, the Department of Health and Social Care (DHSC) said on Friday evening. Continue reading...